Model
Edge
RVL Pharmaceuticals
0001767593
Filing Type
4
Filing Date
7/10/2023
Updated
7/11/23, 3:15 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership